Xtant Medical (XTNT) and Pinnacle Spine entered into a joint agreement to expand distribution of Pinnacle’s InFill® Lateral Lumbar Interbody Fusion (LLIF) system. This marks XTNT’s entry into the lateral lumbar interbody fusion market.
Pinnacle’s InFill platform allows surgeons to deliver an optimal volume of graft to the implant in situ without disrupting placement of the interbody device, thus supporting maximum bone graft-to-endplate contact. The LLIF system is intended for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1.
Xtant Medical (XTNT) and Pinnacle Spine entered into a joint agreement to expand distribution of Pinnacle's InFill® Lateral Lumbar Interbody Fusion (LLIF) system. This marks XTNT's entry into the lateral lumbar interbody fusion market.
Pinnacle's InFill platform allows surgeons to deliver an optimal volume of graft to the implant in...
Xtant Medical (XTNT) and Pinnacle Spine entered into a joint agreement to expand distribution of Pinnacle’s InFill® Lateral Lumbar Interbody Fusion (LLIF) system. This marks XTNT’s entry into the lateral lumbar interbody fusion market.
Pinnacle’s InFill platform allows surgeons to deliver an optimal volume of graft to the implant in situ without disrupting placement of the interbody device, thus supporting maximum bone graft-to-endplate contact. The LLIF system is intended for use at either one level or two contiguous levels in the lumbar spine, from L2 to S1.
Copy to clipboard 
